Literature DB >> 1640633

Liver test alterations with total parenteral nutrition and nutritional status.

L A Leaseburge1, N J Winn, P R Schloerb.   

Abstract

Liver test abnormalities are a well-recognized complication in the parenterally fed population. Numerous etiologies for the development of elevated liver tests have been suggested. However, the etiology and clinical significance remain unclear. The aim of this retrospective study was to determine the extent of liver-associated test (LAT) abnormalities in patients receiving total parenteral nutrition (TPN) and to investigate whether the composition of TPN solutions and the magnitude of malnutrition could be used to predict subsequent LAT abnormalities. Medical records of 78 adult patients who received TPN for at least 2 weeks were reviewed. All subjects had normal LAT results before TPN, were not receiving hepatotoxic drugs, and had no underlying liver disease. Aspartate aminotransferase peaked transiently during week 2 and returned to normal during week 4. Alkaline phosphatase and total bilirubin peaked during weeks 4 and 3, respectively. The average nonprotein kilocalorie distribution was approximately 80% dextrose and 20% lipid. Caloric intake ranged from 7% to 23% above estimated needs. The mean nutritional status score was 22 +/- 15, with a possible range of 0 to 75 (0 indicates no malnutrition). The composition of TPN solutions was not significantly associated with the changes in the three LATs during any week of the 4-week study. The nutritional status score was significantly associated (p less than .05) with the change in alkaline phosphatase during week 1. This study confirms that LAT abnormalities occur during TPN, but the composition of the solution has no significant ability to predict subsequent LAT abnormalities.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1640633     DOI: 10.1177/0148607192016004348

Source DB:  PubMed          Journal:  JPEN J Parenter Enteral Nutr        ISSN: 0148-6071            Impact factor:   4.016


  5 in total

1.  Role of perioperative parenteral nutrition in severely malnourished patients with Crohn's disease.

Authors:  Guo-Xiang Yao; Xiu-Rong Wang; Zhu-Ming Jiang; Si-Yuang Zhang; An-Ping Ni
Journal:  World J Gastroenterol       Date:  2005-09-28       Impact factor: 5.742

2.  Anabolic therapy with growth hormone accelerates protein gain in surgical patients requiring nutritional rehabilitation.

Authors:  T A Byrne; T B Morrissey; C Gatzen; K Benfell; T V Nattakom; M R Scheltinga; M S LeBoff; T R Ziegler; D W Wilmore
Journal:  Ann Surg       Date:  1993-10       Impact factor: 12.969

3.  A new treatment for patients with short-bowel syndrome. Growth hormone, glutamine, and a modified diet.

Authors:  T A Byrne; R L Persinger; L S Young; T R Ziegler; D W Wilmore
Journal:  Ann Surg       Date:  1995-09       Impact factor: 12.969

4.  The effect of sustained delivery of vascular endothelial growth factor on angiogenesis in tissue-engineered intestine.

Authors:  Flavio G Rocha; Cathryn A Sundback; Nicholas J Krebs; J Kent Leach; David J Mooney; Stanley W Ashley; Joseph P Vacanti; Edward E Whang
Journal:  Biomaterials       Date:  2008-04-08       Impact factor: 12.479

5.  Olive Oil and Soybean Oil Based Intravenous Lipid Emulsions, Liver Biochemistry and Clinical Outcomes.

Authors:  Fabio Araujo; Tanis R Fenton; Sara Lukmanji; Maitreyi Raman
Journal:  Nutrients       Date:  2018-05-23       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.